PI CME is a self-directed, web-based activity designed
to help you evaluate your practice.
The activity is comprised of 3 stages:
Stage A -
Perform 10 patient chart reviews from the condition selected, evaluate your
results, and self-identify areas of improvement
Stage B - Based on results of
Stage A, develop and implement an improvement plan
Stage C - Evaluate
improvements and perform a second
chart review for 10 additional patients with the condition selected seen after
your improvement plan is implemented
participation in this activity, you should be able to, in your clinical practice
• Identify the diagnostic tests necessary to conduct to ensure
accurate diagnosis of the cause of urticaria
• Describe current
recommendations for the appropriate treatment and management of patients with
• Assess the benefits and drawbacks of specific treatments
for chronic urticaria according to current evidence
Patient Inclusion Criteria
• Patient with a diagnosis of
chronic urticaria (urticaria that has been continuously or intermittently
present for 6 weeks or longer)
Performance Improvement CME – Chronic Urticaria is
offered free of charge due to the support of an educational grant from
CME only available to purchasers. CME Expires
NOTE: Purchasing this PI CME activity does not enroll
the purchaser in the Maintenance of Certification (MOC) program. For
more information about MOC, please contact that American Board of
Dermatology directly at (617) 910-6400 or visit www.abderm.org
The American Academy of Dermatology is
accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
AMA PRA Credit Designation
The American Academy of Dermatology
designates this Performance Improvement CME activity for a maximum of 20 AMA
PRA Category 1 Credits™.
Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AAD Recognized Credit
This CME activity is recognized by
the American Academy of Dermatology for 20 AAD Recognized Credits and may be
used toward the American Academy of Dermatology's Continuing Medical Education
American Board of Dermatology and American Board of Allergy and
Immunology Maintenance of Certification Approval
Improvement CME – Chronic Urticaria has been approved by the American Board of
Dermatology to satisfy part of Component 4, Evaluation of Performance in
Practice, of the Maintenance of Certification.
The American Board of Allergy and Immunology has approved this performance
improvement module to meet the requirements for Part IV of their Maintenance of
Certification (MOC) program.
For ABD diplomates who have completed this activity in its entirety (Stages
A, B and C), participation in this activity will appear on your AAD Continuing
Professional Development Transcript. You also need to update your ABD profile to
report completion of a MOC Component 4 activity at www.abderm.org.
For ABAI diplomates who have completed this activity in its entirety (Stages
A, B and C), the AAAAI will send your completion data to The American Board of
Allergy & Immunology for MOC Part IV credit.